Verve Therapeutics Insider Trades

VERV

Track insider trading activity from Verve Therapeutics executives and directors. See which insiders are buying and selling VERV stock.

Trades Last 12 Months

All Insider Trades for Verve Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Yeshwant Krishna 10% owner
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.98M 178,339 shares
$11.13
$11.13
Ashe Andrew D. See Remarks
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$3.66M 348,828 shares
$10.50
$11.13
Coats Lonnel Director
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.98M 178,339 shares
$11.13
$11.13
Cumbo Alexander Director
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.98M 178,339 shares
$11.13
$11.13
Dorval Allison Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.75M 255,000 shares
$10.77
$11.13
Gv 2017 Gp, L.L.C. 10% owner
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$18.9M 1,800,000 shares
$10.50
$11.13
Kathiresan Sekar Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15M 1,350,518 shares
$11.13
$11.13
Lister Troy Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.63M 326,500 shares
$11.13
$11.13
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.98M 178,339 shares
$11.13
$11.13
Mikhail Sheila Director
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.47M 221,537 shares
$11.13
$11.13
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.45M 309,741 shares
$11.13
$11.13
Nickerson Joan Chief Administrative Officer
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$183k 17,420 shares
$10.50
$11.13
Politi Jason Chief Technical Ops. Off.
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$172k 16,405 shares
$10.50
$11.13
Tatsis Ourania Director
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.45M 309,741 shares
$11.13
$11.13
Adelman Burt A Director
Holding Value $0 0 shares
Last Trade
Jul 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.47M 221,537 shares
$11.13
$11.13
Bellinger Andrew Chief Scientific Officer
Holding Value $2M 180,000 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 180,000 shares
$12.75
$11.13
Fiedorek Fred T. Chief Medical Officer
Holding Value $1M 90,000 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 90,000 shares
$12.75
$11.13
Evans John M. Director
Holding Value $173k 15,500 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 15,500 shares
$14.04
$11.13
Holding Value $173k 15,500 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 15,500 shares
$14.04
$11.13
Redmile Group, Llc 10% owner
Holding Value $9.87M 886,530 shares
Last Trade
Jun 21, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$32.8M 886,530 shares
$37.00
$11.13

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up